Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Spinocerebellar ataxia type 34 (SCA34) is caused by autosomal dominant variants in ELOVL4, presenting with late-onset cerebellar ataxia and variable skin findings. Over 60 unrelated cases have been reported to date, establishing a robust case series (PMID:36696030).
Inheritance is autosomal dominant, with heterozygous missense alleles segregating in multiple kindreds, including six affected relatives in a French-Canadian family (PMID:32211516) and father–child pairs in a Japanese cohort (PMID:31105016).
The variant spectrum comprises at least five recurrent missense changes in ELOVL4; the c.698C>T (p.Thr233Met) allele is observed in multiple families and reclassified as likely pathogenic after segregation analysis (PMID:36696030).
Functional studies support a dominant-negative mechanism: mutant ELOVL4 mislocalizes from the ER, impairing very long-chain saturated fatty acid synthesis. Knock-in rat models expressing p.Trp246Gly exhibit cerebellar long-term potentiation and depression defects without overt neurodegeneration (PMID:34227061).
Clinically, affected individuals manifest gait and limb ataxia (88–77%), dysarthria (63%), nystagmus (58%), pyramidal tract signs, cognitive impairment, and universal cerebellar atrophy on MRI (PMID:36696030).
Together, multiple independent families, segregation evidence, and concordant functional models support a Strong ELOVL4–SCA34 association. ELOVL4 genetic testing is recommended for autosomal dominant ataxia irrespective of dermatological features.
Gene–Disease AssociationStrong60 cases including multiple unrelated families; autosomal dominant segregation; concordant functional data Genetic EvidenceStrong~60 probands with heterozygous ELOVL4 variants, segregation in 8 affected relatives, multiple recurrent missense alleles Functional EvidenceModerateCellular mislocalization and VLC-SFA deficiency in vitro; knock-in rat synaptic plasticity defects replicating ataxia |